You are here: Home Paxil

Paxil

E-mail Print PDF

Paxil is an antidepressant drug belonging to the class of SSRIs (selective serotonin re-uptake inhibitor).

A significant number of people taking Paxil have learned that stopping this drug can cause quite distressing physical and psychological symptoms (see Side Effects). As a result, a number of these victims have banded together and filed a class action lawsuit in California. This lawsuit alleges that Glaxo SmithKline has known for years the distinct characteristics of Paxil which make it prone to cause withdrawal reactions when discontinued. According to World Health Organization data, Paxil has the highest incidence rate of withdrawal adverse experiences of any antidepressant in the world.

While Glaxo SmithKline (GSK), the manufacturer of Paxil, provides an abundance of information to the public and medical community about the alleged positive aspects of its drug, (through advertising on television and in newspapers and magazines, promotional material provided to doctors, sponsorship of studies, medical meetings and seminars, substantial donations to mental health groups and organizations, government lobbying efforts, etc.), this site provides a collection of information and links not readily available to the public. Why isn’t the information presented on this website more well known? Because the manufacturer of Paxil (as well as the other manufacturers of SSRIs), wants it that way. If asked, GSK might well tell you that, if people were told the truth about Paxil’s potential to produce severe adverse reactions (including withdrawal reactions), these individuals -- who might have benefited from taking the drug -- would be scared away from taking it, to their own detriment. It is up to you, not GSK, to decide what is best for you AFTER full disclosure about the possible side effects of this drug.

We live in a world deluged with marketing of various products. In this current climate, consumers must keep themselves informed in order to protect themselves from over-zealous marketing campaigns. Consumers should be given both sides (“fair balance”) of the information regarding Paxil in order to make an informed choice about their lives and their health. This site gives you the “other” side of Paxil and, by comparing it to GSK information, it is hoped that a fair balance will be achieved.

 

Fill Out a Form

Defective Drugs Form


 

Basic Information

 
 
 
 
 
 

Details About Injury

 
Drug Complained of:
 
 
 
  
 
 

FDA Recalls

Food and Drug Administration--Recalls/Safety Alerts
  • LL Bakery, Inc. Announces the Recall of White Farm Enriched White Bread, Butter Farm Enriched White Bread, and Italian Cream Danish for Undeclared Milk Allergens
    LL Bakery Inc. of Torrance, CA is recalling all White Farm Enriched White Bread, Butter Farm Enriched White Bread, and Italian Cream Danish because product labels fail to declare the allergen "milk", in the whey powder listed in their ingredient statements. People who have an allergy or severe sensitivity to milk run the risk of a life threatening allergic reaction, anaphylaxis, that requires immediate medical attention should they consume these products.
  • Eco-Cuisine Recalls Product Because of Possible Health Risk
    Eco-Cuisine of Boulder, Colorado is recalling all lots of T3314 Basic Brownie Mix, T3333 Betty Brownie Mix with Vanilla, T3388 Ground Beef Style Quick Mix, T3394 Sausage Style Quick Mix, T3416 Chocolate Cookie Mix, T3417 Lemon Muffin Mix, and T3418 English Scone Mix, CM25COOK Basic Cookie Mix 25 lb. bag, CM25MUFF Basic Muffin Mix 25 lb. bag, CM25SCON Basic Scone Mix 25 lb. Bag, because it has the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
  • Sandoz US Announces Voluntary Nationwide Recall of two lots of Methotrexate Sodium, USP, Injectable Vials, 25mg/mL, 40mL vials
    Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the discovery of particulate matter in vials during routine quality examination of retention samples at the manufacturer. The product is preservative free.